Delivery Order SPE2DB20D3103-SPE2DB24FM1C6
- Not listed
- This federal contract award is for the delivery of Moderna COVID-19 vaccine doses (0.25 mL) for the 6-month to 11-year-old age group under Emergency Use Authorization (EUA). The $1,476.88 firm-fixed-price Delivery Order was awarded to Amerisourcebergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA), a major U.S. Department of Defense (DoD) agency responsible for providing logistics and acquisition support to the U.S. Armed Forces. Amerisourcebergen, a large...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The $1,476.88 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which serves as the primary supplier of pharmaceutical and medical products to the Department of Defense (DoD) and other government agencies. This...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under an Emergency Use Authorization. The $28,608.20 fixed-price delivery order contract has a completion date of July 9, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of Moderna COVID-19 vaccines for children aged 6 months to 11 years old, under the Emergency Use Authorization (EUA). The contract, valued at $4,556.76, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is November 6, 2023. The contract is not designated as a set-aside....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The $2,215.32 firm-fixed-price contract is a delivery order without a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will provide the 0.25 mL vaccine doses to support the DLA's mission of supplying medical commodities to the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Moderna COVID-19 vaccines for the 6 month to 11 year old age group under the Emergency Use Authorization (EUA). The contract is a firm fixed-price delivery order with a ceiling value of $1,290.00 and a period of performance through March 13, 2025. The contract does not have a set-aside designation, indicating open competition....
- This contract award is for the delivery of Moderna COVID-19 vaccines (0.25 mL) for individuals aged 6 months to 11 years under the Emergency Use Authorization (EUA). The contract, valued at $3,797.30, was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This is a firm fixed price delivery order contract that does not have a...
- This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,272.22 Firm Fixed Price contract is for the delivery of Moderna COVID-19 vaccine doses (0.25mL) for ages 6 months to 11 years under the Emergency Use Authorization. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen is a for-profit...
- This federal contract award, valued at $4,556.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). This is a firm-fixed-price contract with a completion date of November 13, 2023. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the federal government...
- This federal contract award is for the delivery of 0.25 mL doses of the Moderna COVID-19 vaccine for the 6-month to 11-year age group under the Emergency Use Authorization (EUA). The $1,290.00 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 30, 2024 and does not have a set-aside designation, indicating...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FM1C6Delivery Order
This federal contract award is for the delivery of Moderna COVID-19 vaccines (0.25 mL dose) for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The $12,800.00 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of January 23, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is registered in the System for Award Management (SAM.gov) as a for-profit organization. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 12/29/23 |